Paclitaxel API
| Name of Product | Paclitaxel |
|---|---|
| CAS No | 33069‑62‑4 |
| Therapeutic use:- | Antineoplastic mitotic inhibitor (taxane class) – broad solid tumors |
| Grade | IP/BP/USP |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Paclitaxel API is determined as an anticancer compound which is derivative from Taxus brevifolia.
Known as one of the highly effective chemotherapeutic agents and that works with the stabilisation of microtubules and prevents cell division.
This API leads to inhibition of cell division and cancer cell death.
Paclitaxel is also used for the use towardsoncology treatments.
Therapeutic Applications
Majorly seen to be useful towards breast cancer treatment and in mixture with other agents.
Specialists also consider it for ovarian cancer as it is effective in advanced and recurrent cases.
Paclitaxel is administered with platinum-based drugs.
Commonly prescribed for AIDS-related cases.
Also investigated in prostate, bladder, and pancreatic cancers.
Specification Parameters
Packaging & Storage
Paclitaxel is packed in a sealed glass vial; it could also be in Aluminium foil bags, and bulk packaging is done as per request.
The temperature required is between (2–8°C) (in a day and in a dark environment).
The container has to be kept sealed.
Why Choose Us
Choosing us ensures consistent quality and compliance with international manufacturing standards.
We are also known as a reliable export service provider to major research institutions and pharma companies.
We support bulk order options and flexible packaging.